Potential role of Akt signaling in chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 30, Issue 3, 2015, Pages 385-394

  Lan, Aiping ^a   Du, Jie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

chronic kidney diseases; mesangial cells; podocytes; renal fibroblasts; tubular epithelial cells

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CYTOKINE; GLUCOSE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA1;

CELL GROWTH; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC KIDNEY DISEASE; DISEASE COURSE; ENZYME ACTIVATION; HUMAN; KIDNEY CELL; KIDNEY FIBROSIS; KIDNEY INJURY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CHRONIC KIDNEY FAILURE; METABOLISM; PATHOLOGY;

ANIMALS; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION;

EID: 84924356978     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu196     Document Type: Review

References (143)

1. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047
2. United States Renal Data system. Annual Data Report 2009 (online) 2010
3. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 2000; 15: 290-301
4. Klahr S, Morrissey J. Progression of chronic renal disease. Am J Kidney Dis 2003; 41: S3-S7
5. Owen WF, Jr. Patterns of care for patients with chronic kidney disease in the United States: dying for improvement. J Am Soc Nephrol 2003; 14: 76-80
6. Port FK, Fenton SSA. ESRD throughout the world: morbidity, mortality and quality of life. Kidney Int 2000; 57: S1-S2
7. Johnson RJ, Alpers CE, Yoshimura A et al. Renal injury from angiotensin II-mediated hypertension. Hypertension 1992; 19: 464-474
8. Ketteler M, Noble NA, Border WA. Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis? Annu Rev Physiol 1995; 57: 279-295
9. Tamaki K, Okuda S, Ando T et al. TGF-beta 1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 1994; 45: 525-536
10. Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996; 7: 2495-2508
11. Sharma K, Ziyadeh FN. The transforming growth factor-beta system and the kidney. Semin Nephrol 1993; 13: 116-128
12. Haberstroh U, Zahner G, Disser M et al. TGF-beta stimulates rat mesangial cell proliferation in culture: role of PDGF beta-receptor expression. Am J Physiol 1993; 264: F199-F205
13. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331: 1286-1292
14. Edwards DR, Leco KJ, Beaudry PP et al. Differential effects of transforming growth factor-beta 1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts. Exp Gerontol 1996; 31: 207-223
15. ten Dijke P, Hill CS. New insights into TGF-βSmad signaling. Trends Biochem Sci 2004; 29: 265-273
16. Bakin AV, Tomlinson AK, Bhowmick NA et al. Phosphatidylinositol 3-kinase function is required for transforming growth factor betamediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000; 275: 36803-36810
17. Pouysségur J, Volmat V, Lenormand P. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Biochem Pharmacol 2002; 64: 755-763
18. Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 2004; 9: 667-676
19. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007; 129: 1261-1274
20. Dummler B, Hemmings BA. Physiological roles of PKB/Akt isoforms in development and disease. Biochem Soc Trans 2007; 35: 231-235
21. Cohen MM, Jr. The AKT genes and their roles in various disorders. Am J Med Genet A 2013; 161: 2931-2937
22. Yang ZZ, Tschopp O, Hemmings-Mieszczak M et al. Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J Biol Chem 2003; 278: 32124-32131
23. Kohn AD, Summers SA, Birnbaum MJ et al. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 1996; 271: 31372-31378
24. Hers I, Vincent EE, Tavaré JM. Akt signalling in health and disease. Cell Signal 2011; 23:1515-1527
25. Bellacosa A, Testa JR, Staal SP et al. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 1991; 254: 274-277
26. Franke TF, Yang SI, Chan TO et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995; 81: 727-736
27. Andjelković M, Jakubowicz T, Cron P et al. Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RACPK/ PKB) promoted by serum and protein phosphatase inhibitors. Proc Natl Acad Sci USA 1996; 93: 5699-5704
28. Leslie NR, Batty IH, Maccario H et al. Understanding PTEN regulation: PIP2, polarity and protein stability. Oncogene 2008; 27: 5464-5476
29. Stahl PJ, Felsen D. Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: implications for fibrosis in kidney disease. Am J Pathol 2001; 159: 1187-1192
30. Iwano M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens 2004; 13: 279-284
31. Winbanks CE, Grimwood L, Gasser A et al. Role of the phosphatidylinositol 3-kinase and mTOR pathways in the regulation of renal fibroblast function and differentiation. Int J Biochem Cell Biol 2007; 39: 206-219
32. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004; 15: 1-12
33. Schlondorff D. The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J 1987; 1: 272-281
34. Zhang G, Moorhead PJ, el Nahas AM. Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol 1995; 3: 308-318
35. Eddy AA. Progression in chronic kidney disease. Adv Chronic Kidney Dis 2005; 12: 353-365
36. Hewitson TD. Renal tubulointerstitial fibrosis: common but never simple. Am J Physiol Renal Physiol 2009; 296: F1239-F1244
37. Grande MT, López-Novoa JM. Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat Rev Nephrol 2009; 5: 319-328
38. Floege J, Eitner F, Alpers CE. A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 2008; 19: 12-23
39. Howe AK, Juliano RL. Distinct mechanisms mediate the initial and sustained phases of integrin-mediated activation of the Raf/MEK/mitogenactivated protein kinase cascade. J Biol Chem 1998; 273: 27268-27274
40. Ricupero DA, Poliks CF, Rishikof DC et al. Phosphatidylinositol 3-kinase-dependent stabilization of alpha1(I) collagen mRNA in human lung fibroblasts. Am J Physiol Cell Physiol 2001; 281: C99-C105
41. Ivarsson M, McWhirter A, Borg TK et al. Type I collagen synthesis in cultured human fibroblasts: regulation by cell spreading, platelet-derived growth factor and interactions with collagen fibers. Matrix Biol 1998; 16: 409-425
42. Chaudhary LR, Hruska KA. The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells. J Cell Biochem 2001; 81: 304-311
43. Wisdom R, Huynh L, Hsia D et al. RAS and TGF-beta exert antagonistic effects on extracellular matrix gene expression and fibroblast transformation. Oncogene 2005; 24: 7043-7054
44. Varga J, Bashey RI. Regulation of connective tissue synthesis in systemic sclerosis. Int Rev Immunol 1995; 12: 187-199
45. Branton MH, Kopp JB. TGF-beta and fibrosis. Microbes Infect 1999; 1: 1349-1365
46. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342: 1350-1358
47. Cheng J, Grande JP. Transforming growth factor-beta signal transduction and progressive renal disease. Exp Biol Med (Maywood) 2002; 227: 943-956
48. Kim SE, Lee WJ, Choi KY. The PI3 kinase-Akt pathway mediates Wnt3a-induced proliferation. Cell Signal 2007; 19: 511-518
49. Kim CS, Kim JK, Nam SY et al. Low-dose radiation stimulates the proliferation of normal human lung fibroblasts via a transient activation of Raf and Akt. Mol Cells 2007; 24: 424-430
50. Hutchison N, Fligny C, Duffield JS. Resident mesenchymal cells and fibrosis. Biochim Biophys Acta 2013;1832: 962-971
51. Fuentes-Calvo I, Blázquez-Medela AM, Eleno N et al. H-Ras isoform modulates extracellular matrix synthesis, proliferation, and migration in fibroblasts. Am J Physiol Cell Physiol 2012; 302: C686-C697
52. Fuentes-Calvo I, Crespo P, Santos E et al. The small GTPase N-Ras regulates extracellular matrix synthesis, proliferation and migration in fibroblasts. Biochim Biophys Acta 2013; 1833: 2734-2744
53. Collado M, Medema RH, Garcia-Cao I et al. Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1. J Biol Chem 2000; 275: 21960-219608
54. Feutz AC, Barrandon Y, Monard D. Control of thrombin signaling through PI3K is a mechanism underlying plasticity between hair follicle dermal sheath and papilla cells. J Cell Sci 2008; 121: 1435-1443
55. Kapoor M, Liu S, Shi-wen X et al. GSK-3beta in mouse fibroblasts controls wound healing and fibrosis through an endothelin-1-dependent mechanism. J Clin Invest 2008; 118: 3279-3290
56. Pericacho M, Velasco S, Prieto M et al. Endoglin haploinsufficiency promotes fibroblast accumulation during wound healing through Akt activation. PLoS One 2013; 8: e54687
57. Schnaper HW, Hayashida T, Hubchak SC et al. TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 2003; 284: F243-F252
58. Eddy AA, Neilson EG. Chronic kidney disease progression. J Am Soc Nephrol 2006; 17: 2964-2966
59. Ziyadeh FN. Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol 2004; 1: S55-S57
60. Böttinger EP. TGF-beta in renal injury and disease. Semin Nephrol 2007; 27: 309-320
61. Iwano M, Kubo A, Nishino T et al. Quantification of glomerular TGFbeta 1 mRNA in patients with diabetes mellitus. Kidney Int 1996; 49: 1120-1126
62. Kopp JB, Factor VM, Mozes M et al. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 1996; 74: 991-1003
63. Border WA, Noble NA. Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy. Kidney Int 1998; 54: 1390-1391
64. Ziyadeh FN, Hoffman BB, Han DC et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 2000; 97: 8015-8020
65. Ghosh Choudhury G, Abboud HE. Tyrosine phosphorylation-dependent PI 3 kinase/Akt signal transduction regulates TGFbeta-induced fibronectin expression in mesangial cells. Cell Signal 2004; 16: 31-41
66. Das F, Ghosh-Choudhury N, Mahimainathan L et al. Raptor-rictor axis in TGFbeta-induced protein synthesis. Cell Signal 2008; 20: 409-423
67. Lamouille S, Derynck R. Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 2007; 178: 437-451
68. Mahimainathan L, Das F, Venkatesan B et al. Mesangial cell hypertrophy by high glucose is mediated by downregulation of the tumor suppressor PTEN. Diabetes 2006; 55: 2115-2125
69. Das F, Ghosh-Choudhury N, Venkatesan B et al. Akt kinase targets association of CBP with SMAD 3 to regulate TGFbeta-induced expression of plasminogen activator inhibitor-1. J Cell Physiol 2008; 214: 513-527
70. Runyan CE, Schnaper HW, Poncelet AC. The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1. J Biol Chem 2004; 279: 2632-2639
71. Qi W, Chen X, Poronnik P et al. Transforming growth factor-beta/ connective tissue growth factor axis in the kidney. Int J Biochem Cell Biol 2008; 40: 9-13
72. Zhou G, Li C, Cai L. Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway. Am J Pathol 2004; 165: 2033-2043
73. Abboud HE. Growth factors in glomerulonephritis. Kidney Int 1993; 43: 252-267
74. Silver BJ, Jaffer FE, Abboud HE. Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens. Proc Natl Acad Sci USA 1989; 86: 1056-1060
75. McMahon B, Stenson C, McPhillips F et al. Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors. J Biol Chem 2000; 275: 27566-27575
76. Mitchell D, Rodgers K, Hanly J et al. Lipoxins inhibit Akt/PKB activation and cell cycle progression in human mesangial cells. Am J Pathol 2004; 164: 937-946
77. Krepinsky JC, Li Y, Chang Y et al. Akt mediates mechanical straininduced collagen production by mesangial cells. J Am Soc Nephrol 2005; 16: 1661-1672
78. Chiang CK, Sheu ML, Hung KY et al. Honokiol, a small molecular weight natural product, alleviates experimental mesangial proliferative glomerulonephritis. Kidney Int 2006; 70: 682-689
79. Lloberas N, Cruzado JM, Franquesa M et al. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats. J Am Soc Nephrol 2006; 17: 1395-1404
80. Nagai K, Matsubara T, Mima A et al. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. Kidney Int 2005; 68: 552-561
81. Bahlmann FH, Song R, Boehm SM et al. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 2004; 110: 1006-1012
82. Cho H, Mu J, Kim JK et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2. Science 2001; 292: 1728-1731
83. George S, Rochford JJ, Wolfrum C et al. A family with severe insulin resistance and diabetes due to a mutation in Akt2. Science 2004; 304: 1325-1328
84. Welsh GI, Hale LJ, Eremina V et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab 2010; 12: 329-340
85. Tejada T, Catanuto P, Liaz A et al. Failure to phosphorylate Akt in podocytes from mice with early diabetic nephropathy promotes cell death. Kidney Int 2008; 73: 1385-1393
86. Schlondorff J. Nephrin AKTs on actin: the slit diaphragm-actin cytoskeleton signaling network expands. Kidney Int 2008; 73: 524-526
87. Kriz W, Gretz N, Lemley KV. Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 1998; 54: 687-697
88. Huber TB, Hartleben B, Kim J et al. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 2003; 23: 4917-4928
89. Schiffer M, Bitzer M, Roberts IS et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 2001;108: 807-816
90. Ding G, Reddy K, Kapasi AA et al. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 2002; 283: F173-F180
91. Wada T, Pippin JW, Marshall CB et al. Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins. J Am Soc Nephrol 2005;16: 2615-2625
92. Susztak K, Raff AC, Schiffer M et al. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006; 55: 225-233
93. Tejada T, Catanuto P, Ijaz A et al. Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death. Kidney Int 2008; 73: 1385-1393
94. Bussolati B, Deregibus MC, Fonsato V et al. Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidylinositol 3-kinase/AKT-signaling pathway. J Am Soc Nephrol 2005; 16: 1936-1947
95. Schiffer M, Mundel P, Shaw AS et al. A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-betainduced apoptosis. J Biol Chem 2004; 279: 37004-37012
96. Logar CM, Brinkkoetter PT, Krofft RD et al. Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo. Kidney Int 2007; 72: 489-498
97. Tsui CC, Shankland SJ, Pierchala BA. Glial cell line-derived neurotrophic factor and its receptor ret is a novel ligand-receptor complex critical for survival response during podocyte injury. J Am Soc Nephrol 2006; 17: 1543-1552
98. Chen C, Liang W, Jia J et al. Aldosterone induces apoptosis in rat podocytes: role of PI3-K/Akt and p38MAPK signaling pathways. Nephron Exp Nephrol 2009; 113: e26-e34
99. Canaud G, Bienaimé F, Viau A et al. AKT2 is essential to maintain podocyte viability and function during chronic kidney disease. Nat Med 2013; 19: 1288-1296
100. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010; 21: 212-222
101. Iwano M, Plieth D, Danoff TM et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-350
102. Fragiadaki M, Mason RM. Epithelial-mesenchymal transition in renal fibrosis-evidence for and against. Int J Exp Pathol 2011; 92: 143-150
103. Kriz W, Kaissling B, Le Hir M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 2011; 121: 468-474
104. Böttinger EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol 2002; 13: 2600-2610
105. Li JH,WangW, Huang XR et al. Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway. Am J Pathol 2004; 164: 1389-1397
106. Wang W, Huang XR, Canlas E et al. Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circ Res 2006; 98: 1032-1039
107. Kattla JJ, Carew RM, Heljic M et al. Protein kinase B/Akt activity is involved in renal TGF-beta1-driven epithelial-mesenchymal transition in vitro and in vivo. Am J Physiol Renal Physiol 2008; 295: F215-F225
108. Lee YJ, Han HJ. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells. Am J Physiol Renal Physiol 2010; 298: F1263-F1275
109. Lee JY, Chang JW, Yang WS et al. Albumin-induced epithelialmesenchymal transition and ER stress are regulated through a common ROS-c-Src kinase-mTOR pathway: effect of imatinib mesylate. Am J Physiol Renal Physiol 2011; 300: F1214-F1222
110. Wei X, Wang X, Xia Y et al. Kindlin-2 regulates renal tubular cell plasticity by activation of Ras and its downstream signaling. Am J Physiol Renal Physiol 2013 (epub ahead of print)
111. Yao Y,Wei H, Liu L et al. Upregulated DJ-1 promotes renal tubular EMT by suppressing cytoplasmic PTEN expression and Akt activation. J Huazhong Univ Sci Technolog Med Sci 2011; 31: 469-475
112. Dieter M, Palmada M, Raiamanickam J et al. Regulation of glucose transporter SGLT1 by ubiquitin ligase Nedd4-2 and kinases SGK1, SGK3, and PKB. Obes Res 2004; 12: 862-870
113. Ishiki M, Klip A. Minireview: recent developments in the regulation of glucose transporter-4 trffic: new signals, Locations, and partners. Endocrinology 2005; 146: 5071-5078
114. Whiteman EL, Cho H, Bimbaum MJ. Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab 2002; 13: 444-451
115. Carranza A, Musolino PL, Villar M et al. Signaling cascade of insulininduced stimulation of L-dopa uptake in renal proximal tubule cells. Am J Physiol Cell Physiol 2008; 295: C1602-C1609
116. Green CJ, Goransson O, Kular GS et al. Use of Akt inhibitor and drugresistant mutant validates a critical role for protein kinase B/Akt in the insulin-dependent regulation of glucose and system A amino acid uptake. J Biol Chem 2008; 283: 27653-27667
117. Koulen P, Madry C, Duncan RS et al. Progesterone potentiates IP (3)-mediated calcium signaling through Akt/PKB. Cell Physiol Biochem 2008; 21: 161-172
118. Vaughan-Jones RD, Swietach P. Pushing and pulling the cardiac sodium/ hydrogen exchanger. Circ Res 2008; 103: 773-775
119. Lee IH, Dinudom A, Sanchez-Perez A et al. Akt mediates the effect of insulin on epithelial sodium channels by inhibiting Nedd4-2. J Biol Chem 2007; 282: 29866-29873
120. Mannack G, Graf D, Donner MM et al. Taurolithocholic acid-3 sulfate impairs insulin signaling in cultured rat hepatocytes and perfused rat liver. Cell Physiol Biochem 2008; 21: 137-150
121. Kempe DS, Siraskar G, Frohlich H et al. Regulation of renal tubular glucose reabsorption by Akt2/PKBβ. Am J Physiol Renal Physiol 2010; 298: F1113-F1117
122. Rodríguez-Peña AB, Santos E, Arévalo M et al. Activation of small GTPase Ras and renal fibrosis. J Nephrol 2005; 18: 341-349
123. Li L, Zepeda-Orozco D, Black R et al. Autophagy is a component of epithelial cell fate in obstructive uropathy. Am J Pathol 2010; 176: 1767-1778
124. Periyasamy-Thandavan S, Jiang M, Schoenlein P et al. Autophagy: molecular machinery, regulation, and implications for renal hypertrophy. Am J Physiol Renal Physiol 2009; 297: F244-F256
125. Chen JK, Chen J, Neilson EG et al. Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy. J Am Soc Nephrol 2005; 16: 1384-1391
126. Kim WY, Nam SA, Song HC et al. The role of autophagy in unilateral ureteral obstruction rat model. Nephrology 2012; 17: 148-159
127. Coulson MT, Jablonski P, Howden BO et al. Beyond operational tolerance: effect of ischemic injury on development of chronic damage in renal grafts. Transplantation 2005; 80: 353-361
128. Andreucci M, Michael A, Kramers C et al. Renal ischemia/reperfusion and ATP depletion/repletion in LLC-PK(1) cells result in phosphorylation of FKHR and FKHRL1. Kidney Int 2003; 64: 1189-1198
129. Cai Z, Semenza GL. Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury. Circulation 2004; 109: 2050-2053
130. Müller C, Dünschede F, Koch E et al. Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/ Akt pathway. Am J Physiol Gastrointest Liver Physiol 2003; 285: G769-G778
131. Okumura H, Nagaya N, Itoh T et al. Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway. Circulation 2004; 109: 242-248
132. Zhuang S, Schnellmann RG. H2O2-induced transactivation of EGF receptor requires Src and mediates ERK1/2, but not Akt, activation in renal cells. Am J Physiol Renal Physiol 2004; 286: F858-F865
133. Kwon DS, Kwon CH, Kim JH et al. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells. Eur J Cell Biol 2006; 85: 1189-1199
134. Xie L, Zheng X, Qin J et al. Role of PI3-kinase/Akt signalling pathway in renal function and cell proliferation after renal ischaemia/reperfusion injury in mice. Nephrology (Carlton) 2006; 11: 207-212
135. Sharples EJ, Patel N, Brown P et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 2004; 15: 2115-2124
136. Luo Y, Shoemaker AR, Liu X et al. Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo. Mol Cancer Ther 2005; 4: 977-986
137. Cherrin C, Haskell K, Howell B et al. An allosteric Akt inhibitor effectively blocks Akt signaling and tumor growth with only transient effects on glucose and insulin levels in vivo. Cancer Biol Ther 2010; 9: 493-503
138. Yap TA, Patnaik FIA, Fearen T et al. ASCO Annual Meeting, 2010; p. 62, Abstract 2010
139. Vogelbacher R, Wittmann S, Braun A et al. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat. Transplantation 2007; 84: 1492-1499
140. Gonçalves GM, Cenedeze MA, Feitoza CQ et al. The role of immunosuppressive drugs in aggravating renal ischemia and reperfusion injury. Transplantation 2007; 39: 417-442
141. Fuller FT, Freise CE, Serkova N et al. Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplatation 2003; 76: 1594-1599
142. Lieberthal W, Fuhro R, Andry C et al. Rapamycin delays but does not prevent recovery from acute renal failure: role of acquired tubular resistance. Transplantation 2006; 82: 17-22
143. Coombes JD, Mreich E, Liddle C et al. Rapamycin worsens renal function and intratubular cast formation in protein overload nephropathy. Kidney Int 2005; 68: 2599-2607